Brightfield Group and HelloMD Release Largest Study on CBD Derived from Cannabis

Geplaatst op: 17-11-2017

Finds High Consumer Satisfaction with Using CBD to Treat a Variety of Medical Conditions

Brightfield Group, a premiere market research firm focused on the legal cannabis industry, in partnership with HelloMD, the leading digital healthcare platform for cannabis, today announced the results of a comprehensive study on CBD usage. The study surveyed 2,400 of HelloMD’s 150,000 community members on their usage, knowledge, perceptions, and misconceptions of CBD, making it the largest study of its kind. Overall, the study found that consumers of CBD are very satisfied with its effectiveness for treating a variety of medical conditions including insomnia, depression, anxiety, and joint pain.

CBD, or Cannabidiol, is one of two primary cannabinoids found in marijuana. Unlike THC, the primary psychoactive cannabinoid in marijuana, CBD is non-psychoactive, non-habit forming, and can be extracted from Hemp as well as marijuana. CBD is known to have anti-inflammatory, anti-anxiety, anti-psychotic, and anti-convulsant properties.

“We are seeing an exponential rise in the interest of CBD products from our patient community—particularly among women,” said Dr. Perry Solomon, Chief Medical Officer of HelloMD. “While we still have much to learn about CBD, we cannot ignore this one fact; the majority of those using CBD product today receive great benefit. This has the potential for far-reaching consequences.”

Key findings from the study include:

CBD is most commonly used to treat insomnia, depression, anxiety, and joint pain
42 percent of CBD users stopped using traditional medications and now use cannabis instead
80 percent of CBD users found CBD be very or extremely effective for treatment
90 percent of those surveyed said they would buy CBD-only products derived from marijuana

“This study is exciting because it shows there is potentially a huge barely-tapped market for CBD products that could improve the lives of many people. With further research and public education, CBD could be an effective alternative treatment for many people, particularly at a time when our nation is in the midst of an opioid crisis,” said Bethany Gomez, Director of Research for Brightfield Group.